OBMCX
Price
$46.80
Change
+$0.02 (+0.04%)
Updated
Aug 7 closing price
Net Assets
760.86M
WCMLX
Price
$12.92
Change
-$0.03 (-0.23%)
Updated
Aug 7 closing price
Net Assets
43.74M
Interact to see
Advertisement

OBMCX vs WCMLX

Header iconOBMCX vs WCMLX Comparison
Open Charts OBMCX vs WCMLXBanner chart's image
Oberweis Micro-Cap
Price$46.80
Change+$0.02 (+0.04%)
VolumeN/A
Net Assets760.86M
WCM Small Cap Growth Institutional
Price$12.92
Change-$0.03 (-0.23%)
VolumeN/A
Net Assets43.74M
OBMCX vs WCMLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OBMCX vs. WCMLX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBMCX is a Hold and WCMLX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OBMCX has more cash in the bank: 761M vs. WCMLX (43.7M). OBMCX (0.00) and WCMLX (0.00) have matching dividends . OBMCX was incepted earlier than WCMLX: OBMCX (30 years) vs WCMLX (6 years). WCMLX (1.79) is less costly to investors than OBMCX (1.47). WCMLX is a more actively managed with annual turnover of: 83.00 vs. OBMCX (51.00). OBMCX has a lower initial minimum investment than WCMLX: OBMCX (1000) vs WCMLX (100000). OBMCX annual gain was more profitable for investors over the last year : 19.25 vs. WCMLX (7.56). OBMCX return over 5 years is better than : 115.97 vs. WCMLX (15.42).
OBMCXWCMLXOBMCX / WCMLX
Total Expense Ratio1.470.99148%
Annual Report Gross Expense Ratio1.471.7982%
Fund Existence30 years6 years-
Gain YTD3.7710.700539%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets761M43.7M1,741%
Annual Yield % from dividends0.000.00-
Returns for 1 year19.257.56255%
Returns for 3 years42.4511.25377%
Returns for 5 years115.9715.42752%
Returns for 10 years149.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APLS24.330.60
+2.53%
Apellis Pharmaceuticals
MRAM6.030.09
+1.52%
Everspin Technologies
MKC70.240.81
+1.17%
McCormick & Company
AMLX7.84-0.35
-4.27%
Amylyx Pharmaceuticals
NCNA0.03-0.01
-18.81%
NuCana plc